Polar Capital Holdings PLC Guardant Health, Inc. Transaction History

Polar Capital Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Dec 13, 2023	BUY	$20.94 - $38.01 $209,609 - $380,480	10,010 New	10,010 $358,000
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $209,609 - $380,480	10,010 New	10,010 $358,000
Q2 2022 Aug 15, 2022	SELL	$28.82 - $77.35 $879,211 - $2.36 Million	-30,507 Reduced 45.4%	36,690 $1.48 Million
Q1 2022 May 16, 2022	SELL	$48.25 - $100.49 $3.05 Million - $6.36 Million	-63,261 Reduced 48.49%	67,197 $4.45 Million
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $38.9 Million - $52.7 Million	-437,951 Reduced 77.05%	130,458 $13 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $9 Million - $12 Million	-91,135 Reduced 13.82%	568,409 $71.1 Million
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $3.83 Million - $5.79 Million	-34,924 Reduced 5.03%	659,544 $81.9 Million
Q1 2021 May 17, 2021	BUY	$127.04 - $179.1 $88.2 Million - $124 Million	694,468 New	694,468 $106 Million

325

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.